MedTrace Logo

COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey

NCT04470648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2026-01-26

No results posted yet for this study

Summary

Study of COVID-19 seroprevalence in precarious population living in shelters of Samusocial de Paris and in staff working in these centers during COVID-19 epidemic.

Conditions

  • SARS-COV2 Infection

Interventions

DIAGNOSTIC_TEST

blood test for SARS-COV2 serology

each person who will accept to participate will have a bood test for a SARS-COV2 serology

Sponsors & Collaborators

  • Samusocial de Paris

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Yazdan Yazdanpanah, MD PHD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2021-04-08
Completion
2021-08-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04470648 on ClinicalTrials.gov